|
Volumn 23, Issue 2, 2003, Pages 195-197
|
Clinical implication of the changes of cAMP, TXA 2 and PGI 2 in CSF of asphyxiated newborns
a a a a a |
Author keywords
3', 5' cyclic adenosine monophosphate; Asphyxia; Cerebrospinal fluid; Neonate infant; Prostacyclins; Thromboxane A 2
|
Indexed keywords
3', 5'-CYCLIC ADENOSINE MONOPHOSPHATE (CAMP);
ASPHYXIA;
NEONATE INFANT;
PROSTACYCLINS;
BODY FLUIDS;
CONCENTRATION (PROCESS);
NEUROLOGY;
PATIENT TREATMENT;
TOXICITY;
FETAL MONITORING;
6 OXOPROSTAGLANDIN F1 ALPHA;
BIOLOGICAL MARKER;
CYCLIC AMP;
PROSTACYCLIN;
THROMBOXANE A2;
THROMBOXANE B2;
ARTICLE;
BRAIN ISCHEMIA;
CEREBROSPINAL FLUID;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
NEWBORN;
NEWBORN HYPOXIA;
6-KETOPROSTAGLANDIN F1 ALPHA;
ASPHYXIA NEONATORUM;
BIOLOGICAL MARKERS;
CYCLIC AMP;
EPOPROSTENOL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPOXIA-ISCHEMIA, BRAIN;
INFANT, NEWBORN;
MALE;
THROMBOXANE A2;
THROMBOXANE B2;
|
EID: 3142642651
PISSN: 0257716X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|